Inhibitory Effects of Green Tea against Squalene Synthase |
Choi, Sung-Won
(Department of Food and Culinary Art, Osan College)
Hur, Nam-Yoon (Department of Food and Culinary Art, Osan College) Lee, Han-Seung (Department of Bio-Food Materials, College of Medical and Life Sciences, Silla University) Baik, Moo-Yeol (Department of Food Science and Biotechnology, Kyung Hee University) Ahn, Soon-Cheol (Department of Microbiology and Immunology, Pusan National University School of Medicine) Lee, Jeong-Gyu (Department of Family Medicine, Pusan National University School of Medicine) |
1 | Hasumi, K., C. Shinohara, T. Iwanaga and A. Endo. 1993. Laterin, A new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gibberella lateritium IFO 7188. J. Antibiotics 46, 782-780 |
2 | Park, J. K., K. Hasumi and A. Endo. 1993. Inhibitors of acyl- CoA: cholesterol acyltrans- ferase by Helminthosporol and its related compounds. J. Antibiotics 46, 1303-1310 DOI ScienceOn |
3 | Cohen, L. H., A. M. Griffioen and R. J. A. Wanders. 1986. Regulation of squalene synthase in rat liver. Biochem. Biophy. Res. Commu. 138, 335-341 DOI ScienceOn |
4 | Dugan, R. E. and J. W. Porter. 1972. Hog liver squalene synthase : The partial purification of the particulate enzyme and kinetic analysis of the reaction. Arch. Biochem. Biophy. 152, 28-35 DOI ScienceOn |
5 | Heider, J. G. 1986. Agent which inhibit cholesterol esterification in the intestine andtheir potential value in the treatment of hypercholesterolemia. J. R. Prous Science Publishers. pp. 423-438 |
6 | Keller, R. K. and F. Vilsaint. 1993. Regulation of isoprenoid metaboliosm in rat liver: near constnat chain lengths of dolichy phosphate and ubiquinone are maintained during greatly altered rates of cholesterogenesis. Biochim. Biophy. Acta. 1170, 20-25 |
7 | Feussner, G. 1994. HMG CoA reductase inhibitors. Curr. Opin. Lipidol. 5, 59-68 DOI ScienceOn |
8 | Stedronsky, E. R. 1994. Interaction of bile acids and cholesterol with non-systematic agents having hypocholesterolemic properties. Biochimica. et Biophysica. Acta. 1210, 255- 262 DOI ScienceOn |
9 | Biller, S. A., C. Forster, E. M. Gordon, T. Harrity, W. A. Scott and P. Ciosek. 1988. Isoprenoid (phosphinylmethyl) phosphonates as inhibitors of squalene synthetase. J. Med. Chem. 31, 1869-1871 DOI |
10 | Tomada, H., H. Nishida, R. Masuda, J. Cao, S. Okuda and S. Omura. 1991. Purpactins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Penicillium purpurogenum I. Production, isolation and physico-chemical and biological properties. J. Antibiotics 44, 136-145 DOI |
11 | Hertog, M. G., D. Kromhort, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Monotti and S. Nedeljkovic. 1995. Flavonoid intake and long-term risk of coronary heart diseases and cancer in the seven countries study. Arch. Int. Med. 155, 381-386 DOI ScienceOn |
12 | Papjak, G., D. S. Goodman, J. W. Cornforth, R. H. Cornforth and R. Ryhage. 1961. Studies on the biosynthesis of cholesterol: X V. Mechanism of squalene biosynthesis from farnesyl pyrophosphate and from mevalonate. J. Biol. Chem. 236, 1934-1939 |
13 | Agnew, W. S. 1985. Squalene synthetase. Methods in Enzymology. 110, 359-375 DOI |
14 | Bergstrom, J. D., M. M. Krutz, D. J. Rew, A. M. Amend, J. D. Karkas, R. D. Bostedor, V. S. Bansal, C. Dufresns, F. L. Van Middleworth, O. D. Hensens, J. M. Liesch, D. L. Zinc, K .E. Wilson, J. Onishi, J. A. Milligan, G. Bills, L. Kaplan, M. Nallin Omsted, R. G. Jenskins, L. Huang, M. S. Meinz, L. Quinn, R. U. Burg, Y. L. Kong, S. Mochales, M. Mojena, I. Martin, F. Pelaez, M. T. Diez and A. W. Albert. 1993. Zaragozic acids: A Family of metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90, 80-89 DOI ScienceOn |
15 | Biller, S. A., C. Forster, E. M. Gordon, T. Harrity, L. C. Rich, J. Marretta and P. Ciosek. 1991. Isoprenyl phosphi nylformates: new inhibitors of squalene synthetase. J. Med. Chem. 34, 1914-1916 DOI |
16 | Shechter, I., I. Klinger and M. L. Rucher. 1992. Solubilization and characterization of a truncated form of rat hepatic squalene synthase. J. Biol. Chem. 267, 8628-8635 |
17 | Jin, H. H., J. L. Yang, J. H. Chung and Y. Kim. 2004. Hypocholesterolemic effects of green tea in cholesterol-fed rats. J. Korean Soc. Food Sci. Nutr. 33, 47-51 DOI ScienceOn |
18 | Sidebottom, P. J., R. M. Highcock, S. J. Lane, P. A. Procopiou and N. S. Watson. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation. J. Antibiotics 45, 648-658 DOI |
19 | Brown, M. S. and J. L. Goldstein. 1980. Multivalent feedback regulation of HMG-CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21, 505-512 |
20 | Dawson, M. J., J. E. Farthing, P. S. Marshall, R. F. Middleton, M. J. O'Neill, A. Shuttleworth, C. Stylli, R. M. Tait, P. M. Taylor, H. G. Wildman, A. D. Buss, D. Langley and M. V. Hayes. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Toxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiotics 45, 639-647 DOI |
21 | Spector, A. A. and M. A. Yorek. 1985. Membrane lipid composition and cellular function. J. Lipid Res. 26, 1015- 1021 |
22 | Abe, I., J. C. Tomesch, S. Wattanasin and G. D. Prestwich. 1993. Inhibitors of squalene biosynthesis and metabolism. Natural Product Reports 11, 279-293 DOI ScienceOn |
23 | Poulter, C. D. and H. C. Rilling. 1991. Biosynthesis of isoprenoid compounds. pp. 413-441, Wiley, New York |
24 | Yamaguchi, Y., M. Hayashi, H. Yamazoe, M. Kunitomo. 1991. Preventive effects of green tea extract on lipid abnormalities in serum, liver and aorta of mice fed a atherogenic diet. Nippon Yakurigaku Zasshi 7, 329-337 |
25 | Kuswik, R. G. and H. C. Rilling. 1987. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities. J. Biol. Chem. 262, 1505-1510 |
26 | Naganuma, S., Sakai, K. Hasumi and A. Endo. 1992. Acaterin, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Pseudomonas sp. A92. J. Antibiotics 45, 1216-1223 DOI |
27 | Padley, F. B. and J. Podmore. 1985. The role of fats in human nutrition. pp. 7-15, Ellis Horwood. Chichester |
28 | Tijburg, L. B., T. Mattern, J. D. Folts, U. M. Weigerber and M. B. Katen. 1997. Tea flavonoids and cardiovascular disease: a review. Crit. Rev. Food Sci. Nutr. 37, 771-785 DOI ScienceOn |
29 | Baxter, A., B. J. Fitzgerald, J. L. Hutson, A. D. McCarthy, J. M. Motteram, B. C. Ross, M. Sapra. M. A. Snowden, N. S. Watson, R. J. Williarm and C. Wright. 1992. Squalestatin I, a potent inhibitor of squalene synthase, which lower serum cholesterol in vivo. J. Biol. Chem. 267, 11705-11708 |
30 | Goldstein, J. L. and S. M. Brown. 1990. Regulation of the mevalonate pathway. Nature 33, 425-433 DOI |
31 | Yeo, S. G., C. W. Lee, Y. W. Lee, T. G. Lee, Y. H. Park and S. B. Kim. 1995. Antioxidant effect of tea extract from green tea, Oolong tea and black tea. J. Korean Soc. Food Nutr. 24, 299-304 |
32 | Park, C. O., S. H. Jin, and B. H. Ryu. 1996. Antioxidant activity of green tea extracts toward human low density lipoprotein. Korean J. Food Sci. Technol. 28, 850-858 |